MAPT and Cognitive impairment: Indeed, in this study we also found that APOE4 is associated with prevalence of AD-tau pathology as well as worsen amyloid score in our cohort composed of cognitively unimpaired individuals, individuals with mild cognitive impairment, and AD cases.